SLC6A1‑miR133a‑CDX2 loop regulates SK‑OV‑3 ovarian cancer cell proliferation, migration and invasion
Authors:
Open Access
- 7 August 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 16 (4) , 4977-4983
Abstract
The present study assessed the expression of solute carrier 6 member 1 (SLC6A1) in ovarian cancer (OC) tissues and evaluated the effect of silencing SLC6A1 or caudal type homeobox 2 (CDX2) on the proliferation, migration, and invasion of SK‑OV‑3 OC cells. The levels of caudal type homeobox 2 (CDX2) and SLC6A1 mRNA were also examined in OC SK‑OV‑3, OVCAR3 and A2780 cell lines. The mRNA levels of CDX2 and SLC6A1 in SK‑OV‑3 OC cells were assessed following transection with microRNA (miR) 133a mimics; the mRNA and protein levels of SLC6A1 were determined following the silencing of CDX2, and the mRNA expression of CDX2 was gauged following the silencing of SLC6A1. A luciferase reporter assay was performed to assess the effect of miR133a on the CDX2 and SLC6A1 3'‑untranslated regions (3'UTRs). The proliferation, migration and invasion rate of SK‑OV‑3 cells were then examined following the silencing of CDX2 or SLC6A1. The expression of SLC6A1 was increased in OC compared with adjacent tissue. The expression of CDX2 and SLC6A1 in SK‑OV‑3 and OVCAR3 cells was increased compared with A2780 cells (P<0.05). The level of CDX2 and SLC6A1 mRNA in SK‑OV‑3 cells decreased when the cells were transected with the miR133a mimics, compared with a negative control (P<0.05). Transfection with the miR133a mimics significantly reduced the luciferase activity of reporter plasmids with the SLC6A1 or CDX2 3'UTRs (P<0.05). The mRNA level of CDX2 was decreased subsequent to the silencing of SLC6A1; the mRNA and protein level of SLC6A1 were decreased when CDX2 was silenced (P<0.05). The proliferation, migration, and invasion of SK‑OV‑3 cells were significantly reduced following the silencing of CDX2 or SLC6A1 (P<0.05). CDX2 may therefore be inferred to promote the proliferation, migration and invasion in SK‑OV‑3 OC cells, acting as a competing endogenous RNA.Keywords
This publication has 55 references indexed in Scilit:
- Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progressionOncology Letters, 2014
- CA19-9 elevation in ovarian mature cystic teratoma: Discrimination from ovarian cancer – CA19-9 level in teratomaMedical Science Monitor, 2013
- In Vivo Identification of Tumor- Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of MelanomaCell, 2011
- Identification of a Smad4/YY1-Recognizedand BMP2-Responsive Transcriptional RegulatoryModule in the Promoter of Mouse GABA Transporter Subtype I (Gat1) GeneJournal of Neuroscience, 2010
- EdU incorporation is an alternative non-radioactive assay to [3H]thymidine uptake for in vitro measurement of mice T-cell proliferationsJournal of Immunological Methods, 2009
- The biology of ovarian cancer: new opportunities for translationNature Reviews Cancer, 2009
- The role of Cdx genes in the mammalian gutGut, 2004
- Pattern of expression of cyclin D1/CDK4 complex in human placenta during gestationCell and tissue research, 2004
- CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 geneOncogene, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001